27 July 2020

Amedeo Smart

Independent Medical Education

Subscriber: th..@boehringer-ingelheim.com

HIV Infection

27 July 2020 | n=81

  1. Pastakia SD, Braitstein P, Galarraga O, Genberg B, et al.
    Preserving two decades of healthcare gains for africa in the Covid-19 era.
    AIDS 2020.

  2. Giatsou E, Abdi B, Plu I, Desire N, et al.
    Ultradeep sequencing reveals HIV-1 diversity and resistance compartmentalization during HIV-encephalopathy.
    AIDS 2020.

  3. Knettel BA, Mwamba RN, Minja L, Goldston DB, et al.
    Exploring patterns and predictors of suicidal ideation among pregnant and postpartum women living with HIV in Kilimanjaro, Tanzania.
    AIDS 2020.

  4. Sabo MC, Lehman DA, Pintye JC, Wang B, et al.
    Elevation of Cervical CXCL10 Levels is Associated with HIV-1 Acquisition in Pregnant and Postpartum Women.
    AIDS 2020.

  5. Cachay ER, Torriani FJ, Hill L, Jain S, et al.
    The role of barriers to care on the propensity for HCV non-referral among people living with HIV.
    AIDS 2020.

  6. Tshivuila-Matala C, Honeyman S, Nesbitt C, Kirtley S, et al.
    Perinatal outcomes associated with antiretroviral therapy: systematic review and network meta-analysis of randomised controlled trials.
    AIDS 2020.

  7. Trunfio M, Rugge W, Mighetto L, Vai D, et al.
    Dual antiretroviral therapies are effective and safe regimens in the central nervous system of neurologically symptomatic people living with HIV.
    AIDS 2020.

  8. Mai B, Wang W, Lin M, Hu S, et al.
    HIV-Associated plasmablastic lymphoma in the era of highly active antiretroviral therapy: a single center experience of 21 patients.
    AIDS 2020.

  9. Hughes K, Akturk G, Gnjatic S, Chen B, et al.
    Proliferation of HIV-infected renal epithelial cells following virus acquisition from infected macrophages.
    AIDS 2020.

  10. Wall KM, Kilembe W, Inambao M, Hoagland A, et al.
    Cost-effectiveness of integrated HIV prevention and family planning services for Zambian couples.
    AIDS 2020.

  11. Bobrow K, Xia F, Hoang T, Valcour V, et al.
    HIV and risk of dementia in older veterans.
    AIDS 2020.

  12. Charre C, Icard V, Pradat P, Brochier C, et al.
    COVID-19 attack rate in HIV-infected patients and in PrEP users.
    AIDS 2020.

  13. Jones DL, Alcaide VJR, Luisa M, Carrico A, et al.
    Syndemic burden and systemic inflammation, HIV health status, and blood pressure among women with unsuppressed HIV viral loads in the Women's Interagency HIV Study.
    AIDS 2020.

  14. Lang R, Czarnecki C, Kim J, Luider J, et al.
    Identification and root-cause analysis of aberrant CD4 counts in an HIV cohort; the importance of quality control in changing laboratory procedure.
    AIDS 2020.

  15. Abdi B, Nguyen T, Brouillet S, Desire N, et al.
    No HIV-1 molecular evolution on long term antiretroviral therapy initiated during primary HIV-1 infection.
    AIDS 2020.

  16. Pyra M, Rusie L, Castro M, Baker KK, et al.
    A taxonomy of pragmatic measures of HIV pre-exposure prophylaxis (PrEP) Use: application in a PrEP-using cohort in Chicago, IL.
    AIDS 2020.

  17. Eggers C, Hoetelmans R, Laer S.
    Zidovudine and lamivudine reach higher concentrations in ventricular than in lumbar human cerebrospinal fluid.
    AIDS 2020.

  18. Medina N, Alastruey-Izquierdo A, Mercado D, Bonilla O, et al.
    Comparative performance of the laboratory assays used by a diagnostic laboratory hub for opportunistic infections in people living with HIV.
    AIDS 2020.

  19. Dhande JR, Saikia K, Singh DP, Bagul RD, et al.
    Higher frequencies of functional HIV-Envelope specific memory B cells are associated with non-progressive HIV infection in Indian population.
    AIDS 2020.

  20. Ferrara M, Bumpus NN, Ma Q, Ellis RJ, et al.
    Antiretroviral drug concentrations in brain tissue of adult decedents.
    AIDS 2020.

  21. Lebelonyane R, Mills LA, Mogorosi C, Ussery F, et al.
    Advanced HIV disease in the botswana combination prevention project: prevalence, risk factors, and outcomes.
    AIDS 2020.

  22. Boesecke C.
    Recently acquired and early chronic hepatitis C in men having sex with men (MSM): Recommendations from the NEAT-ID consensus panel.
    AIDS 2020.

  23. Inzaule SC, Jordan MR, Cournil A, Giron-Callejas A, et al.
    Tenofovir resistance in early and long-term treated patients on first-line antiretroviral therapy in eight low- and middle-income countries.
    AIDS 2020.

  24. Collins LF, Moran CA, Oliver NT, Moanna A, et al.
    Clinical characteristics, comorbidities and outcomes among persons with HIV hospitalized with coronavirus disease 2019 in Atlanta, GA.
    AIDS 2020.

  25. Feiterna-Sperling C, Bukkems VE, Teulen MJA, Colbers AP, et al.
    Low raltegravir transfer into the breastmilk of a woman living with HIV.
    AIDS 2020.

  26. Tozzi B, Gavioli C, Linhares L, Entringer M, et al.
    Pruritic papular eruption in HIV-positive patients in Brazil.
    AIDS 2020;34:1576-1578.

  27. Chirwa M, Mazzitelli M, Pereira B, Milinkovic A, et al.
    Incidental findings in elderly people living with HIV undergoing computed tomography coronary artery calcium scoring.
    AIDS 2020;34:1573-1575.

  28. Latini A, Alei L, Magri F, Eibenschutz L, et al.
    Nonmelanoma skin cancer and melanoma in HIV-1-infected patients.
    AIDS 2020;34:1570-1572.

  29. Inzaule SC, Bertagnolio S, Kityo CM, Siwale M, et al.
    The relative contributions of HIV drug resistance, nonadherence and low-level viremia to viremic episodes on antiretroviral therapy in sub-Saharan Africa.
    AIDS 2020;34:1559-1566.

  30. Closson K, McLinden T, Parry R, Lee M, et al.
    Severe intimate partner violence is associated with all-cause mortality among women living with HIV.
    AIDS 2020;34:1549-1558.

  31. Lesko CR, Chander G, Moore RD, Lau B, et al.
    Variation in estimated viral suppression associated with the definition of viral suppression used.
    AIDS 2020;34:1519-1526.

  32. Merchante N, Rodriguez-Fernandez M, Figueruela B, Rodriguez-Arrondo F, et al.
    Impact of HIV on the survival of hepatocellular carcinoma in hepatitis C virus-infected patients.
    AIDS 2020;34:1497-1507.

  33. Mocroft A, Ryom L, Oprea C, Li Q, et al.
    Influence of hepatitis C virus co-infection and hepatitis C virus treatment on risk of chronic kidney disease in HIV-positive persons.
    AIDS 2020;34:1485-1495.

  34. Titanji K, Ofotokun I, Weitzmann MN.
    Immature/transitional B-cell expansion is associated with bone loss in HIV-infected individuals with severe CD4+ T-cell lymphopenia.
    AIDS 2020;34:1475-1483.

  35. Pinacchio C, Scagnolari C, Iebba V, Santinelli L, et al.
    High abundance of genus Prevotella is associated with dysregulation of IFN-I and T cell response in HIV-1-infected patients.
    AIDS 2020;34:1467-1473.

  36. Giron LB, Azzoni L, Yin X, Lynn KM, et al.
    Hepatitis C virus modulates IgG glycosylation in HIV co-infected antiretroviral therapy suppressed individuals.
    AIDS 2020;34:1461-1466.

  37. SahBandar IN, Chew GM, Corley MJ, Pang APS, et al.
    Changes in gastrointestinal microbial communities influence HIV-specific CD8+ T-cell responsiveness to immune checkpoint blockade.
    AIDS 2020;34:1451-1460.

  38. Kahn J.
    The changing HIV epidemic: a view from the front line in the United States.
    AIDS 2020;34:1437-1438.

  39. Citerne Q, Boyer L, Moreau E, Garon J, et al.
    Cluster headache-like symptoms during treatment with tenofovir disoproxil fumarate and emtricitabine.
    AIDS 2019;33:1535-1536.

  40. Van Welzen BJ, Thielen MAJ, Mudrikova T, Arends JE, et al.
    Switching tenofovir disoproxil fumarate to tenofovir alafenamide results in a significant decline in parathyroid hormone levels: uncovering the mechanism of tenofovir disoproxil fumarate-related bone loss?
    AIDS 2019.

  41. Bbosa N, Ssemwanga D, Kaleebu P.
    Choosing the right program for the identification of HIV-1 transmission networks from nucleotide sequences sampled from different populations.
    AIDS Res Hum Retroviruses 2020.

  42. Cary DC, Peterlin M.
    Proteasomal inhibition potentiates latent HIV reactivation.
    AIDS Res Hum Retroviruses 2020.

  43. Al-Harthi L, Campbell EM, Schneider JA, Bennett DA, et al.
    What HIV in the brain can teach us about SARS-CoV-2 neurologic complications?
    AIDS Res Hum Retroviruses 2020.

  44. Shao W, Boltz VF, Hattori J, Bale MJ, et al.
    HIV-DRLink: A Tool for Reporting Linked HIV-1 Drug Resistance Mutations in Large Single-Genome Datasets Using the Stanford HIV Database.
    AIDS Res Hum Retroviruses 2020.

  45. Nasi M, Pecorini S, De Biasi S, Digaetano M, et al.
    Circulating mitochondrial DNA and LPS-binding protein but not bacterial DNA are increased in acute HIV infection.
    AIDS Res Hum Retroviruses 2020.

  46. Taiwo B, Quinones-Mateu ME, Smith K, Zheng L, et al.
    Prior Case of Resistance on Dolutegravir Plus Lamivudine Dual Therapy.
    AIDS Res Hum Retroviruses 2020.

  47. Chandra C, Weiss KM, Kelley CF, Marcus JL, et al.
    Gaps in Sexually Transmitted Infection Screening among Men who Have Sex with Men in PrEP Care in the United States.
    Clin Infect Dis 2020.

  48. Samet JH, Tsui JI, Cheng DM, Liebschutz JM, et al.
    Improving the Delivery of Chronic Opioid Therapy among People Living with HIV: A Cluster Randomized Clinical Trial.
    Clin Infect Dis 2020.

  49. Bekker A, Decloedt EH, Slade G, Cotton MF, et al.
    Single Dose Abacavir Pharmacokinetics and Safety in Neonates Exposed to HIV.
    Clin Infect Dis 2020.

  50. Tan BK, Chalouni M, Ceron DS, Cinaud A, et al.
    Atherosclerotic Cardiovascular Events in Patients Infected With Human Immunodeficiency Virus and Hepatitis C Virus.
    Clin Infect Dis 2020.

  51. Spinelli MA, Lowery B, Shuford JA, Spindler J, et al.
    Use of Drug-Level Testing and Single-Genome Sequencing to Unravel a Case of HIV Seroconversion on PrEP.
    Clin Infect Dis 2020.

  52. Jaklevic MC.
    HIV Antiviral Expanded for Use in Very Young Children.
    JAMA 2020;324:224.

  53. Jankowski CM, Mawhinney S, Wilson MP, Campbell TB, et al.
    Body Composition Changes in Response to Moderate or High-Intensity Exercise Among Older Adults with or without HIV Infection.
    J Acquir Immune Defic Syndr 2020.

  54. O'Brien BE, Williams PL, Huo Y, Kacanek D, et al.
    Repeat Pregnancies Among US Women Living with HIV in the SMARTT Study: Temporal Changes in HIV Disease Status and Predictors of Preterm Birth.
    J Acquir Immune Defic Syndr 2020.

  55. Narsi K, Tomita A, Ramlall S.
    Cognitive reserve and its determinants in newly HIV diagnosed antiretroviral-naive adults from peri-urban and informal settlements: Evidence from an HIV hyperendemic South African setting.
    J Acquir Immune Defic Syndr 2020.

  56. Acosta RK, Willkom M, Andreatta K, Liu H, et al.
    Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) from Dolutegravir (DTG)+F/TAF or DTG+F/Tenofovir Disoproxil Fumarate (TDF) in the Presence of Pre-Existing NRTI Resistance.
    J Acquir Immune Defic Syndr 2020.

  57. John SA, Petroll AE, Walsh JL, Quinn KG, et al.
    Reducing the discussion divide by digital questionnaires in healthcare settings: Disruptive innovation for HIV testing and pre-exposure prophylaxis (PrEP) screening.
    J Acquir Immune Defic Syndr 2020.

  58. Pairoj C, Weerayut T, Sarawut S, Sudarat S, et al.
    Echocardiographic findings among virally suppressed HIV-infected Aging Asians compared to HIV-negative individuals.
    J Acquir Immune Defic Syndr 2020.

  59. Peebles K, Palanee-Phillips T, Balkus JE, Beesham I, et al.
    Age-specific risk scores do not improve HIV-1 prediction among women in South Africa.
    J Acquir Immune Defic Syndr 2020.

  60. Keen P, Lee E, Grulich AE, Prestage G, et al.
    Sustained, low prevalence of undiagnosed HIV among gay and bisexual men in Sydney, Australia coincident with increased testing and pre-exposure prophylaxis use: results from repeated, bio-behavioural studies 2014-2018.
    J Acquir Immune Defic Syndr 2020.

  61. Calon M, Menon K, Carr A, Henry RG, et al.
    Additive and Synergistic Cardiovascular Disease Risk Factors and HIV Disease Markers' Effects on White Matter Microstructure in Virally Suppressed HIV.
    J Acquir Immune Defic Syndr 2020;84:543-551.

  62. Vecchio A, Robertson K, Saylor D, Nakigozi G, et al.
    Neurocognitive Effects of Antiretroviral Initiation Among People Living With HIV in Rural Uganda.
    J Acquir Immune Defic Syndr 2020;84:534-542.

  63. Audsley J, Avihingsanon A, Littlejohn M, Bowden S, et al.
    Long-Term TDF-Inclusive ART and Progressive Rates of HBsAg Loss in HIV-HBV Coinfection-Lessons for Functional HBV Cure?
    J Acquir Immune Defic Syndr 2020;84:527-533.

  64. Sun-Suslow N, Paolillo EW, Morgan EE, Letendre S, et al.
    Brief Report: Frailty and HIV Disease Severity Synergistically Increase Risk of HIV-Associated Neurocognitive Disorders.
    J Acquir Immune Defic Syndr 2020;84:522-526.

  65. de Almeida SM, Ribeiro CE, Tang B, de Pereira AP, et al.
    Neurocytoskeleton Proteins in Cerebrospinal Fluid of People With HIV-1 Subtypes B and C.
    J Acquir Immune Defic Syndr 2020;84:514-521.

  66. Egan JE, Ho K, Stall R, Drucker MT, et al.
    Feasibility of Short-Term PrEP Uptake for Men Who Have Sex With Men With Episodic Periods of Increased HIV Risk.
    J Acquir Immune Defic Syndr 2020;84:508-513.

  67. Hirschhorn LR, Brown RN, Friedman EE, Greene GJ, et al.
    Black Cisgender Women's PrEP Knowledge, Attitudes, Preferences, and Experience in Chicago.
    J Acquir Immune Defic Syndr 2020;84:497-507.

  68. Andrasik MP, Sesay FA, Isaacs A, Oseso L, et al.
    Social Impacts Among Participants in HIV Vaccine Trial Network (HVTN) Preventive HIV Vaccine Trials.
    J Acquir Immune Defic Syndr 2020;84:488-496.

  69. Naugle DA, Dosso A, Tibbels NJ, Van Lith LM, et al.
    Addressing Uptake of HIV Testing and Linkage to Care Among Men in Cote d'Ivoire: An Evaluation of the Brothers for Life Program Implementation.
    J Acquir Immune Defic Syndr 2020;84:480-487.

  70. Ma H, Wang L, Gichangi P, Mochache V, et al.
    Venue-Based HIV Testing at Sex Work Hotspots to Reach Adolescent Girls and Young Women Living With HIV: A Cross-sectional Study in Mombasa, Kenya.
    J Acquir Immune Defic Syndr 2020;84:470-479.

  71. Murenzi G, Kim HY, Munyaneza A, Tuyisenge P, et al.
    Anogenital Human Papillomavirus and HIV Infection in Rwandan Men Who Have Sex With Men.
    J Acquir Immune Defic Syndr 2020;84:463-469.

  72. Zhang W, Hu Q, Tang W, Jin X, et al.
    HIV Self-Testing Programs to Men Who Have Sex With Men Delivered by Social Media Key Opinion Leaders and Community-Based Organizations are Both Effective and Complementary: A National Pragmatic Study in China.
    J Acquir Immune Defic Syndr 2020;84:453-462.

  73. Dasgupta S, Tie Y, Bradley H, Beer L, et al.
    Characteristics of Sexual Partnerships Among Men With Diagnosed HIV Who Have Sex With Men, United States and Puerto Rico-2015-2019.
    J Acquir Immune Defic Syndr 2020;84:443-452.

  74. Sevelius JM, Poteat T, Luhur WE, Reisner SL, et al.
    HIV Testing and PrEP Use in a National Probability Sample of Sexually Active Transgender People in the United States.
    J Acquir Immune Defic Syndr 2020;84:437-442.

  75. van Wyk J, Orkin C, Rubio R, Bogner J, et al.
    Durable Suppression and Low Rate of Virologic Failure 3 Years After Switch to Dolutegravir + Rilpivirine 2-Drug Regimen: 148-Week Results From the SWORD-1 and -2 Randomized Clinical Trials.
    J Acquir Immune Defic Syndr 2020.

  76. Gudipati S, Brar I, Murray S, McKinnon JE, et al.
    Descriptive Analysis of Patients Living with HIV Affected By COVID-19.
    J Acquir Immune Defic Syndr 2020.

  77. Broger T, Nicol M, Sigal G, Gotuzzo E, et al.
    Diagnostic accuracy of three urine lipoarabinomannan tuberculosis assays in HIV-negative outpatients.
    J Clin Invest 2020.

  78. Chazot R, Botelho-Nevers E, Mariat C, Fresard A, et al.
    Cystatin C and urine albumin-to-creatinine ratio predict 5-year mortality and cardiovascular events in People Living with HIV independently of measured GFR.
    J Infect Dis 2020.

  79. Kanwugu ON, Adadi P.
    HIV/SARS-CoV-2 coinfection: a global perspective.
    J Med Virol 2020.

  80. Zhang Y, Kuse N, Akahoshi T, Chikata T, et al.
    Role of escape mutant-specific T cells in suppression of HIV-1 replication and co-evolution with HIV-1.
    J Virol 2020.

  81. Zhu FC, Guan XH, Li YH, Huang JY, et al.
    Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial.
    Lancet 2020.

Display articles in

Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:

Amedeo HIV Infection

Five-Week Literature

03 August 2020

27 July 2020

20 July 2020

13 July 2020

06 July 2020

27 July 2020

Multidisciplinary Journal Club

  1. Campbell BCV, Khatri P.
    Lancet. 2020;396:129-142.

  2. Johnston SC, Amarenco P, Denison H, Evans SR, et al.
    Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA.
    N Engl J Med. 2020;383:207-217.

  3. Muller-Schmitz K, Krasavina-Loka N, Yardimci T, Lipka T, et al.
    Normal pressure hydrocephalus associated with Alzheimer' disease.
    Ann Neurol. 2020 Jul 13. doi: 10.1002/ana.25847.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016